MAPT and Alzheimer disease: At the same time, SGK1 activity in mice was inhibited by SGK1 inhibitor GSK650394, and it was found that this treatment promoted the recovery of normal cognitive behavior and synaptic function of PFC in P301S Tau mice, which verified the relationship between SGK1 and AD in positive and negative aspects (Cao et al., 2020).